focus -WSS

focus

author：hotspot 2025-10-01 21:33:44 - browse：3391

Business standing in the middle of a maze near a bag with a dollar sign on it. -- biotech coverage from STAT — Adobe

Over the last year or two, something curious has started occurring in the conference rooms and private Zoom meetings of biotech venture capitalists.

Representatives from pension funds, college endowments, family offices, and other organizations with money to invest have become bolder in their requests, according to interviews with a host of VCs. They’re pushing not only for advantageous terms in a VC firm’s latest fund, but in some cases, have angled for equity in the firm itself. These types of conditions aren’t unheard of, but have become more frequent as venture capitalists have a harder time raising funds, and as outside investors feel empowered to ask for more bang for their buck.

“A lot is changing in venture fundraising right now,” said Nan Li, co-founder and managing partner of Dimension, which launched last January. Outside investors tried to ask for a piece of Dimension, but the new firm had more than enough interest in its first fund and was able to turn down those proposals. Two other young VC firms told STAT they’ve fielded similar requests, and one investment group reported that it had managed to negotiate an equity stake in a VC firm.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Videos point to link between seizures and unexplained toddler deaths

WSS

AdventHealth escalates lawsuit against insurance vendor Multiplan

UCB departs biotech trade group BIO

Unicorn down: Following layoffs, Biofourmis CEO quietly departs

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

AdventHealth escalates lawsuit against insurance vendor Multiplan

AdventHealth escalates lawsuit against insurance vendor Multiplan

hotspot

focus

hotspot

Tori Bowie and the unacceptable rates of Black maternal death

Complete sequence of Y chromosome published for first time

Apple is now the first public company to be valued at $3 trillion

Why psychiatrists like me stop taking insurance

23andMe had bad news about my health. I wish a person had delivered it

Videos point to link between seizures and unexplained toddler deaths

New air purifier tech could be key to improving indoor air quality

NYU Langone launches private ChatGPT for its health care data

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Neuroscience startup Neumora files for IPO

focus

The biotech scorecard for Q1: 17 stock

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Why psychiatrists like me stop taking insurance

How to make AI work for medicine

J&J to buy cancer drug developer Ambrx Biopharma

Ahead of JPM, here's who's profiting most in health care

explore

Wikipedia

knowledge

Wikipedia